Skip to main content
An official website of the United States government

autologous tumor-infiltrating lymphocytes C-TIL051

A preparation of autologous tumor infiltrating lymphocytes (TILs) derived from each patient's resected tumor and expanded ex vivo, with potential immunomodulating and antineoplastic activities. Upon administration back into the patient, the autologous TILs C-TIL051 specifically recognize and kill the patient's tumor cells.
Synonym:autologous TILs C-TIL051
TILs C-TIL051
Code name:C-TIL 051
C-TIL-051
C-TIL051
Search NCI's Drug Dictionary